Fred Alger Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Sell
26,741
-3,264
-11% -$276K 0.01% 327
2026
Q1
$2.98M Sell
30,005
-264
-0.9% -$34.4K 0.01% 282
2025
Q4
$3.68M Sell
30,269
-120,472
-80% -$15.1M 0.01% 270
2025
Q3
$16.9M Buy
150,741
+113,408
+304% +$13.3M 0.07% 135
2025
Q2
$5M Buy
+37,333
New +$4.1M 0.02% 232
2024
Q4
Sell
-518
Closed -$81.3K 472
2024
Q3
$81.3K Hold
518
﹤0.01% 412
2024
Q2
$78K Sell
518
-119
-19% -$14.3K ﹤0.01% 406
2024
Q1
$47.1K Sell
637
-1,342,278
-100% -$111M ﹤0.01% 431
2023
Q4
$106M Sell
1,342,915
-231,688
-15% -$14M 0.57% 43
2023
Q3
$86.2M Sell
1,574,603
-74,905
-5% -$5.39M 0.5% 51
2023
Q2
$139M Buy
1,649,508
+505,869
+44% +$38.7M 0.71% 27
2023
Q1
$86.6M Buy
1,143,639
+843,434
+281% +$58.3M 0.46% 60
2022
Q4
$18.5M Sell
300,205
-135,643
-31% -$7.21M 0.1% 172
2022
Q3
$18.2M Buy
+435,848
New +$19M 0.09% 174

Other funds holding TMDX

Fred Alger Management's TMDX Position: Q2 2026 in Review

Fred Alger Management reduced its Transmedics (TMDX) stake by 11% in Q2 2026, selling an estimated $276K and leaving 26,741 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #327.

Fred Alger Management first reported a position in TMDX in Q3 2022 and has held it in 14 quarters since. The position peaked at $139M in Q2 2023. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Fred Alger Management held 26,741 shares of Transmedics worth $1.78M as of Q2 2026.
  • Fred Alger Management sold 3,264 Transmedics shares in Q2 2026, an estimated $276K.
  • Transmedics made up 0.01% of Fred Alger Management's portfolio in Q2 2026, its #327 holding.
  • Fred Alger Management first reported a position in Transmedics in Q3 2022 and has held it in 14 quarters since.
  • Fred Alger Management's Transmedics position peaked at $139M in Q2 2023.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.